• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Clinical report outlines health supervision recommendations for patients with achondroplasia

byAlex Gipsman, MDandLeah Carr, MD
May 27, 2020
in Chronic Disease, Endocrinology, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this report, the American Academy of Pediatrics (AAP) provides updated guidelines on diagnosis, genetic counseling, medical evaluation, and anticipatory guidance for pediatricians taking care of individuals with achondroplasia.

2. The report includes recommendations starting from the prenatal period through young adulthood, and addresses the wide array of medical complications that are common in those with achondroplasia.

Report Rundown: Achondroplasia is an autosomal dominant skeletal dysplasia that is the most common cause of severe, disproportionate short stature. Patients are prone to a unique set of medical and psychosocial complications that require careful monitoring and anticipatory guidance. This AAP report (last updated in 2005) provides valuable background information on achondroplasia as well as guidance to primary care providers regarding health supervision. Highlights from the report include:

  • Pediatricians may be asked to provide prenatal counseling to parents of a fetus who is suspected to have achondroplasia based on short long bones found on prenatal ultrasound late in gestation.
  • Diagnosis should always be confirmed with radiographic studies in the newborn period, as physical exam findings may be difficult to ascertain initially.
  • A detailed discussion of the genetics of achondroplasia should take place with the parents. Because it is an autosomal dominant condition, anyone with achondroplasia has a 50% chance of passing it to each of his or her offspring. However, 80% of mutations causing the condition occur de novo.
  • Families should be referred to support groups such as Little People of America to help them manage the potentially significant psychosocial implications of achondroplasia on the entire family.
  • Achondroplasia-specific growth and development charts should be used to assess patients at every health supervision visit.
  • Important medical complications include cervicomedullary compression due to small foramen magnum, central and obstructive sleep apnea, middle ear dysfunction, and hydrocephalus. These can impact health in both the short-term (e.g. during procedures requiring anesthesia, increased risk of sudden infant death, etc.) and long-term.
  • Pediatricians should consider consulting an occupational therapist to help the family adapt their home (i.e. to make toilets, light switches, door handles accessible) to enable their child to become independent.
  • Medication should always be dosed based on patient size, not age.
  • Parents should be thoroughly informed about potential treatment options that have been used in patients with achondroplasia. These include growth hormone therapy, surgical limb lengthening, and new medications currently in trials that may alter bone growth and morphology

Click to read the study in Pediatrics

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

New mutations behind heritable hypercalcemia and hypocalcemia identified

Tags: achondroplasiaautosomal dominantskeletal dysplasia
Previous Post

Characteristics of childhood picky eaters in low-income families

Next Post

Risk of QTc prolongation with hydroxychloroquine therapy

RelatedReports

New mutations behind heritable hypercalcemia and hypocalcemia identified
Chronic Disease

New mutations behind heritable hypercalcemia and hypocalcemia identified

June 27, 2013
Next Post
Risk of QTc prolongation with hydroxychloroquine therapy

Risk of QTc prolongation with hydroxychloroquine therapy

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

Emergency general surgery linked to greater risk of venous thromboembolism than elective surgery

#VisualAbstract: Atezolizumab-bevacizumab treatment increases survival in unresectable hepatocellular carcinoma

#VisualAbstract: Atezolizumab-bevacizumab treatment increases survival in unresectable hepatocellular carcinoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Impact of late ventricular fibrillation on postdischarge 1-year mortality of patients presenting with acute myocardial infarction: a nationwide retrospective study
  • Clinical validation of a frailty management mHealth tool in a cohort of community-dwelling older adults: the Geras Fit-Frailty App
  • 2 Minute Medicine Rewind January 5, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.